St. Jude Medical Inc. Hits New 52-Week High at $54.09 (STJ)
Shares of St. Jude Medical (NYSE:STJ) hit a new 52-week high during mid-day trading on Wednesday, AR Network reports. The stock traded as high as $54.09 and last traded at $54.08, with a volume of 708,020 shares trading hands. The stock had previously closed at $53.81.
A number of research firms have recently commented on STJ. Analysts at Zacks reiterated a “neutral” rating on shares of St. Jude Medical (NYSE:STJ) in a research note to investors on Wednesday. They now have a $57.00 price target on the stock. Separately, analysts at Wells Fargo & Co. upgraded shares of St. Jude Medical (NYSE:STJ) from a “market perform” rating to an “outperform” rating in a research note to investors on Friday, August 9th. Finally, analysts at TheStreet reiterated a “buy” rating on shares of St. Jude Medical (NYSE:STJ) in a research note to investors on Friday, July 19th.
Four analysts have rated the stock with a sell rating, ten have issued a hold rating and thirteen have issued a buy rating to the company’s stock. St. Jude Medical has a consensus rating of “Hold” and a consensus target price of $47.20.
In other St. Jude Medical news, VP Mark Murphy unloaded 4,200 shares of the company’s stock in a transaction that occurred on Wednesday, September 11th. The stock was sold at an average price of $53.50, for a total transaction of $224,700.00. Following the sale, the vice president now directly owns 642 shares in the company. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
St. Jude Medical has a 52-week low of $30.25 and a 52-week high of $54.06. The stock’s 50-day moving average is $52.2 and its 200-day moving average is $46.26. The company has a market cap of $15.517 billion and a price-to-earnings ratio of 25.42.
St. Jude Medical (NYSE:STJ) last posted its quarterly earnings results on Wednesday, July 17th. The company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.02. The company had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.36 billion. During the same quarter in the previous year, the company posted $0.86 earnings per share. The company’s revenue for the quarter was down .5% on a year-over-year basis. Analysts expect that St. Jude Medical will post $3.72 EPS for the current fiscal year.
St. Jude Medical, Inc (NYSE:STJ) develops, manufactures and distributes cardiovascular medical devices.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.